Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001823239-24-000126
Filing Date
2024-12-05
Accepted
2024-12-05 16:49:37
Documents
4
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1733435369.html 3  
1 FORM 3 wk-form3_1733435369.xml 3 1660
2 EX-24 exhibit241section16power.htm EX-24 5262
3 GRAPHIC exhibit241section16power001.jpg GRAPHIC 276341
4 GRAPHIC exhibit241section16power002.jpg GRAPHIC 76659
  Complete submission text file 0001823239-24-000126.txt   494783
Mailing Address THREE RAVINIA DRIVE ATLANTA GA 30346
Business Address
ECKERT R ANDREW (Reporting) CIK: 0001210525 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39725 | Film No.: 241529723

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Issuer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)